We are live on ! Find out more
BCM

Bronte Capital Management Portfolio holdings

AUM $1.01B
1-Year Est. Return 47.99%
This Fund
S&P 500
This Quarter Est. Return
+11.82%
1 Year Est. Return
+47.99%
3 Year Est. Return
+112.22%
5 Year Est. Return
+138.3%
10 Year Est. Return
–
AUM
$1B
AUM Growth
-$114M
Cap. Flow
-$99.2M
Cap. Flow %
-9.89%
Top 10 Hldgs %
77.87%
Holding
47
New
17
Increased
3
Reduced
23
Closed
3

Top Buys

Rank Stock Value
1
TBBB icon
BBB Foods
TBBB
+$11.8M
2
BBWI icon
Bath & Body Works
BBWI
+$3.09M
3
FICO icon
Fair Isaac
FICO
+$2.7M
4
NICE icon
Nice
NICE
+$2.45M
5
TPB icon
Turning Point Brands
TPB
+$2.38M

Top Sells

Rank Stock Value
1
IBB icon
iShares Biotechnology ETF
IBB
+$34M
2
COF icon
Capital One
COF
+$19.7M
3
IBKR icon
Interactive Brokers
IBKR
+$18.4M
4
ABVX
Abivax
ABVX
+$14.9M
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$12.7M

Sector Composition

Rank Sector Weight
1 Financials 25.65%
2 Healthcare 15.18%
3 Communication Services 14.31%
4 Consumer Staples 9.74%
5 Consumer Discretionary 7.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
REGN icon
1
Regeneron Pharmaceuticals
REGN
$78.5B
$136M 13.61%
176,768
-3,515
-2% -$2.39M
GOOGL icon
2
Alphabet (Google) Class A
GOOGL
$4.36T
$130M 12.99%
415,963
-11,176
-3% -$3.19M
IBKR icon
3
Interactive Brokers
IBKR
$39.2B
$95.6M 9.53%
1,486,294
-274,877
-16% -$18.4M
BRK.B icon
4
Berkshire Hathaway Class B
BRK.B
$1.1T
$81.6M 8.14%
162,327
-12,401
-7% -$6.17M
AMZN icon
5
Amazon
AMZN
$2.92T
$64.1M 6.39%
277,641
-13,624
-5% -$3.12M
PM icon
6
Philip Morris
PM
$297B
$63.9M 6.38%
398,556
-19,094
-5% -$2.96M
REGN icon
7
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$45.8M 4.57%
+59,300
New +$40.3M
COF icon
8
Capital One
COF
$128B
$42.5M 4.24%
175,540
-88,569
-34% -$19.7M
CTVA icon
9
Corteva
CTVA
$52.6B
$38.1M 3.8%
569,033
-1,985
-0.3% -$128K
FCNCA icon
10
First Citizens BancShares
FCNCA
$24.9B
$36.6M 3.65%
17,072
-3,548
-17% -$6.69M
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$27.5B
$15.5M 1.54%
38,864
+3,890
+11% +$1.72M
GHC icon
12
Graham Holdings Company
GHC
$5.1B
$14.7M 1.46%
13,355
-42
-0.3% -$44.9K
HLF icon
13
Herbalife
HLF
$1.29B
$14.4M 1.44%
1,120,175
-238,814
-18% -$2.53M
PINS icon
14
Pinterest
PINS
$13.4B
$13.3M 1.32%
512,196
-137,086
-21% -$3.95M
TBBB icon
15
BBB Foods
TBBB
$4.98B
$13.2M 1.31%
+394,158
New +$11.8M
IBB icon
16
iShares Biotechnology ETF
IBB
$9.34B
$12.2M 1.22%
72,350
-209,072
-74% -$34M
SQM icon
17
Sociedad Química y Minera de Chile
SQM
$19.2B
$11.2M 1.12%
163,457
-1,130
-0.7% -$62.2K
SBH icon
18
Sally Beauty Holdings
SBH
$1.43B
$10.5M 1.05%
737,250
-343,945
-32% -$5.18M
NEM icon
19
Newmont
NEM
$98.7B
$7.77M 0.78%
77,856
-159
-0.2% -$14.4K
B
20
Barrick Mining
B
$61.5B
$7.18M 0.72%
164,856
-48,213
-23% -$1.81M
RAMP icon
21
LiveRamp
RAMP
$2.3B
$6.81M 0.68%
231,994
+599
+0.3% +$17.2K
BBWI icon
22
Bath & Body Works
BBWI
$4.06B
$5.11M 0.51%
254,611
+139,810
+122% +$3.09M
MDLZ icon
23
Mondelez International
MDLZ
$79.5B
$3.47M 0.35%
64,547
-1,324
-2% -$76.2K
FICO icon
24
Fair Isaac
FICO
$24.3B
$2.65M 0.26%
+1,567
New +$2.7M
TPB icon
25
Turning Point Brands
TPB
$1.45B
$2.64M 0.26%
+24,372
New +$2.38M
1
2

Similar funds

EPAM
Euro Pacific Asset Management Dorado, Puerto Rico $1.01B AUM 79.26% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
GA
GRS Advisors Chicago, Illinois $1.01B AUM 13.12% 1-Year Est. Return
CT
Coastline Trust Providence, Rhode Island $1.01B AUM 22.57% 1-Year Est. Return
AH
Allen Holding New York $1.01B AUM 27.61% 1-Year Est. Return
PIM
Provident Investment Management Novi, Michigan $1.01B AUM 9.4% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.01B AUM 19.71% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Bronte Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bronte Capital Management held 47 positions worth $1B, down 10% from $1.12B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bronte Capital Management withdrew a net $99.2M in Q4 2025, closing 3 positions and reducing 23 holdings. Its most notable exit was Abivax, an estimated $14.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 30% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Bronte Capital Management opened a new position in BBB Foods worth $13.2M.

  • Bronte Capital Management's largest Q4 2025 buy was BBB Foods: 394,158 shares worth $13.2M.
  • Bronte Capital Management added most to Bath & Body Works in Q4 2025, an estimated $3.09M increase.
  • Bronte Capital Management's biggest Q4 2025 reduction was iShares Biotechnology ETF, cutting an estimated $34M.
  • Bronte Capital Management fully exited Abivax in Q4 2025, selling an estimated $14.9M.
  • Bronte Capital Management's ten largest holdings make up 78% of its $1B portfolio in Q4 2025.
  • Bronte Capital Management opened 17 new positions and closed 3 in Q4 2025.
  • Bronte Capital Management's portfolio value fell 10% quarter-over-quarter to $1B.

Based on Bronte Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.